A contract development and manufacturing organization (CDMO) refers to a company that can provide solutions to pharmaceutical projects from drug development through to drug manufacturing. A CDMO ca

Gene therapy is the utilization of genes to treat or prevent disease. Instead of administering drugs or performing surgery, genetic material is either created, modified or repaired before inserting

What are ADCs?

Antibody drug conjugates (ADCs) are formulated to combine the targeting ability of monoclonal antibodies and the cytotoxic effect of chemotherapy drugs. An ide

Biologics and Biosimilars in Canada

Canada’s spending on prescribed medications was reported to be at $29.4 billion in 2014. This staggering number is already a product of

The ambiguity and uncertainty surrounding the costs to develop a new pharmaceutical drug often frustrate pharmaceutical companies. Despite what it seems, this isn’t some cheap way for drug manufa

In our previous blog on pharmaceutical predictions for 2016 was so popular; we are here for part two of this year’s pharma trends.

Emerging trends in this post include specialty drug spendi

What is CMO?

Contract manufacturer organization (CMO) is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug

In 2015, public spending on prescription drugs in Canada hit over $30 billion. However believe it or not, the annual growth rate of drug spending is the second lowest it’s ever been since 1977. T

Did you know generic drugs are most likely going to cost more from this year onwards? Were you aware that patients have much more options when it comes to treatment than they did 20-30 years ago? T

In our last blog post, we defined technology transfer and its significance in the pharm